Percutaneous transluminal dilatation of peripheral arteries: An analysis of factors predicting early success

Size: px
Start display at page:

Download "Percutaneous transluminal dilatation of peripheral arteries: An analysis of factors predicting early success"

Transcription

1 SYMPOSIUM Interventional Radiology EDITOR'S NOTE: This symposium comprises the papers presented at the combined breakfast program of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter, on June 18, 1983, at the scientific meeting in San Francisco. The subjects were selected by the Program Committee for their value in answering problems of practical clinical import. Percutaneous transluminal dilatation of peripheral arteries: An analysis of factors predicting early success Michael E. Lally, M.D., K. Wayne Johnston, M.D., and David Andrews, Ph.D., Toronto, Ontario, Canada Four hundred ninety-five patients undergoing peripheral arterial percutaneous transluminal dilatation (TLD) with the Gruntzig balloon catheter were studied prospectively to determine which factors could be used to predict a successful result from the procedure. Ten variables were recorded before the TLD. The procedure was considered a success at follow-up if both the clinical grade and the objective vascular laboratory results improved. The results of a logistic discriminant function analysis showed that three variables were associated with success of a TLD at 3 months: the site of the TLD, the severity of the lesion (i.e., stenosis or ocdusion), and the runoff. With these results, logistic regression analysis was used to estimate the chances of a successful result for all combinations of these significant variables. It is concluded that the early result ofa TLD is determined by the site of the TLD, the severity of the lesion, and the runoff. A table of the estimated chances of success for any combination of these variables has been constructed and accurately describes our patient population. (J VASC SURG 1984; 1: ) In spite of some skepticism, percutaneous transluminal dilatation (TLD) is becoming an increasingly popular method for managing selected patients with localized peripheral arterial occlusive disease. The low morbidity and complication rates associated with this procedure make it an attractive option in the treatment of selected patients with ischemic complaints, especially if the patient is a high operative risk or the symptoms are not disabling enough to warrant surgery. Despite these advantages, its overall success rate is lower than reconstructive surgery, and consequently it is desirable to determine which factors predict the result of the procedure. 1,2 The purposes of this article are to ascertain which variables are associated with the success of a From the Departments of Surgery and Biostatistics, The University of Toronto. Reprint requests: K. W. Johnston, M.D., Toronto General Hospital, 915 E-N Eaton Bldg., 200 Elizabeth St., Toronto, Ontario MSG 1L7, Canada. 704 TLD and to develop a mathematical model that will estimate the chances of success for all combinations of the significant variables. METHODS Patients. Data on 495 consecutive patients undergoing TLD at the Toronto General Hospital formed the basis for this study. The patients were included if they were referred for the procedure by one of the physicians or surgeons at the Toronto General Hospital or if their referring physiciarl agreed to allow us to assess and follow-up their patients objectively. Technique. The TLDs were performed by experienced vascular radiologists using the Gruntzig balloon catheter. The details of our technique are similar to Gruntzig's and have been described previ~ ously, a'4 For both iliac and femoral-popliteal dilatations, the catheter was usually introduced through the ipsilateral common femoral artery. Heparin, 5000 units, was given intra-arterially after the ca~ e-

2 Voiume 1 Number 5 September 1984 Percutaneous transluminal dilatation 705 ter was across the stenosis or occlusion and was not reversed at the end of the procedure. The patients received aspirin, 325 mg, and dipyridamole, 50 mg, orally three times daily starting 2 or 3 days prior to the procedure and continued for 1 month. No other long-term anticoagulation was used. Evaluation of results. The result of the TLD was determined with the use of a combination of subjective criteria and objective vascular laboratory measurements. 1"4 For a TLD to be called a success, the following criteria had to be satisfied: the patient's symptoms improving by at least one clinical grade; the ankle/brachial systolic pressure index increasing by at least 0.10; the Doppler pulsatility index increasing by more than 20%; monophasic Doppler waveforms becoming biphasic or triphasic; and the treadmill exercise distance doubling. Variables. Based on the resuks of previous vascular follow-up studies, we hypothesized that the following 10 variables might be related to the success of the procedure, and they were recorded prospectively: age, sex, presence and severity of diabetes, history of previous TLD at the same site, clinical indication for the procedure, site of the dilatation, ankle/brachial pressure ratio before the procedure, severity of the lesion (i.e., stenosis or occlusion), severity of arterial occlusive disease distal to the TLD (i.e., runoff), and occurrence of a complication. The subcategories of these variables are shown in Table I. Data analysis and statistical methods. The patient data were stored on a microcomputer and updated after each patient follow-up visit. The microcomputer was used to tabulate a frequency distribution of the characteristics of the patient population ~d to calculate the long-term results of TLDs by the life-table analysis method. In this study a larger computer was used for the logistic discriminant function analysis and the logistic regression analysis. A logistic discriminant function analysis was performed with the use of the SAS FUNCAT (SAS Institute, Inc., Cary, N.C.) subroutine to identify the variables associated with success. First, the program was used to determine which of the variables most significantly affected the result of the TLD. Second, to assure that none of the remaining variables had significance that might have been concealed in the initial discriminant analysis, the following procedure was adopted. The designated group of significant variables was combined with one of the remaining variables one by one and the FUNCAT procedure repeated. This procedure was repeated with each of the remaining variables, Table I. Variables and characteristics of the study population Variable Patients Subcategories and codes (%) Age (yr) < > Sex Male 65.1 Female 34.9 Diabetes Nil 80.1 Diet controlled 4.3 Oral hypoglycemics 8.3 Insulin dependent 7.3 Previous TLD No 92.9 Yes 7.1 TLD indication Claudication 82.2 Limb salvage 12.5 Other 4.3 Site Common iliac Common and external iliac 8.9 Femoral-popliteal 26.2 Other 8.4 Complications Nil 88.5 Death 0.6 Minor 10.3 Major 0.6 Ankle-pressure ratio < > Severity lesion Stenosis 79.6 Occlusion 20.4 Runoff No distal disease 46.0 <50% stenosis or 1-vessel 13.1 occlusion 50%-99% stenosis or vessel occlusion Complete occlusion or vessel occlusion and the significance of the added variable was assessed. Logistic rcgression analysis was used to estimate the chances of a successful result for all combinations of the significant variables. The success of the procedure dcpends on thc selected variables and logistic rcgression analysis gives estimates of this dependence in the form: L = K + KI~VARIABLE 1 + K2*VARIABLE 2 (1) +... Kn~VARIABLE n where K is a constant and K1, K2,... Kn are the coefficients associated with each ofthc variables and * represents multiplication. A variable may represent the presence of a particular condition. The probability of success of the TLD for each of the combinations of the variables is given by: Probability success = (c~+~l)/ (1 + e**l) (2) where e~+*l represents e raised to the Lth power.

3 706 Lally, Johnston, and Andrews Journal of VASCULAR SURGERY Table. Distribution of patients according to three significant variables < 50% Stenosis or 1 Vessel Occlusion 50-99% Stenosis or 2 Vessel Occlusion Occlusion or 3 Vessel Occlusion Common External Gommon Femorallilac Ilia and popliteal External Iliac -- S~enosis % successful TLDS D% Failed TLDS Height of each box is ~" # TED Patients Fig. 1. Results of logistic discriminant function analysis showing the three variables: site of the TLD, severity of lesion, and runoff. Heights of shaded areas are square root of number of failures; clear areas, square root of number of successes. (This format was used for purposes of scaling in figure.) Forty-one of the 495 procedures were excluded from the analysis because the site of the TLD was uncommon and there were insignificant numbers in the groups to be meaningful. In this study the factors determining early success (defined as success at 3 months) were analyzed. RESULTS Frequency distribution of variables. The characteristics of the study population are shown in Table I. Specifically, the frequency distribution of each of the variables and subcategories are listed. Logistic discriminant function analysis. The logistic discriminant function analysis identified the following three variables as being jointly significant and associated with early (3 months) success of a TLD: the site of the dilatation, the severity of the lesion (presence of stenosis or occlusion), and the status of the runoff. None of the other variables, when added to these three variables, were found to be significant. The distribution of the patients based on these variables is shown in Table. Fig. 1 summarizes the results of the discriminant analysis and demonstrates the interrelationship of the site of the TLD, the severity of the lesion, and the runoff. For each combination of these three significant variables, the height of each histogram is the square root of the number of cases. The shaded area represents the number of failed TLDs and the clear area the number of successes. This figure visually Site (No.) (No.) Common iliac I I I I I I laemoral-popliteal I I I = no runoff disease; = <50% distal stenosis or one- fibial artery occlusion; I = 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial displays the data that have been used for the logistic regression analysis. Logistic regression analysis. With the use of logistic regression analysis, the values of the coefficients K, K1, K2... were determined for the significant variables. For each combination of site,' severity of lesion, and status of runoff; the percentage chance of success of a TLD was calculated by using equation 2. Table IA is a table of the estimated probabilities of success of a TLD for the different combinations of site, severity of lesion, and runoff. Table IB shows the 5% and 95% confidence limits for these estimates. In regard to site, for the different combinations of the variables, this table shows that the best chance for a successful TLD is at the external iliac site, although the common iliac and femoral-popliteal sites have results at 3 months that were nearly identical. When attempts are made to dilate multiple iliac lesions (i.e., a combined common and external iliac lesion), the chance of success is lower. For all combinations of variables, dilatation of a stenotic lesion consistently has a 20% to 25% greater chance of success than dilatation of an occluded artery, and the chances of success are progressively worse as the runoff became poorer. As illustrated in Table, the logistic regression

4 Volume 1 Number 5 September 1984 Percutaneous transluminal dilatation 707 Table IA. Chance of successful TLD at 3 months Site (%) (%) Common iliac I I I I I I Femoral-popliteal I I I = no runoff disease; = <50% distal stenosis or one-tibial artery occlusion; I= 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial equation accurately predicted the probabilities of a successful dilatation. For each combination of variables, the number of TLDs predicted as being successful by the regression analysis closely agreed with the actual number of successful cases. DISCUSSION Transluminal dilatation is an alternative to vascular reconstructive surgery for the treatment of selected patients with peripheral arterial occlusive disease. Its advantages include low morbidity, low mortality, lower cost, short hospital stay, repeatability, low complication rate, and high patient acceptability. Also, TLD can be used as an adjunct to surgery to improve the inflow, thus limiting the extent of the operative procedure, and to treat postoperative complications of saphenous vein bypass grafts or progression of the occlusive disease. Since the mid-1970s, when TLD with the Gruntzig balloon catheter first became popular in North America, most investigators have reported only small retrospective series and have rarely used objective criteria for evaluating the results of the procedure. In contrast, our series is a prospective study of 495 TLDs, and the procedure was considered a success only if there was improvement of both the patients' symptoms and the objective measurements in the vascular laboratory. Table IB. 95% confidence limits of estimated chance of success at 3 months Site (%) (%) Common iliac I I I I I I Femoral-popliteal I I I = no runoff disease; = <50% distal stenosis or one-tibial artery occlusion; I= 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial From a review of the literature it is difficult to determine which factors were important determinants of success; however, the following seem to be important. Site of the TLD. Most authors agree that the best results are obtained in the iliac segment, where success rates at 1 year are 76% to 93% and at 2 years 66% to 92%. 1'2"5-s The reported success rates for femoral-popliteal disease are 51% to 80% at i year and 46% to 75% at 2 years. 1-a'~'8-11 In the series reported here the cumulative success rates for all iliac TLDs at 1 year and 2 years was 71.1 _+ 2.9% (mean +_ 1 SE) and %, respectively, and for the femoral-politeal segment was 56.I +_ 4.8% and %. The results of dilatation of the profunda femoris artery, the common femoral and the tibial arteries have been less satisfactory. Severity of lesion. Some authors are reluctant to dilate occluded vessels because of the potential risk of arterial perforation; however, in our experience this concern is unfounded)7 In the femoralpoptiteal segment, Waltman et a12 reported a success rate of 87.5% for stenoses and 76% for occlusions. In our previous study we noted a 60% cumulative success rate at 1 year for stenoses and 40% for occlusions. Although the same trend has been re-

5 708 Lally, Johnston, and Andrews Journal of VASCULAR SURGERY Table. Number of TLDs predicted successful by logistic regression analysis/actual number of successful results Site (No.) (No.) Common lilac I 73/73 14/16 12/12 1/2 I 13/11 1/1 27/26 1/1 I 37/35 3/2 13/12 1/1 I 15/17 0/0 1V 27/28 1/1 I 14/17 3/4 2/2 1/0 I 2/0 0/0 8/8 1/0 FemoralTopliteal I 34/34 15/13 13/13 9/9 I 12/13 8/8 7/7 7/8 I = no runoff disease; = <50% distal stenosis or one- tibial artery occlusion; I = 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial ported in the iliac segment, we have had excellent results with dilatation of occluded iliac arteries. 4'7 Runoff. There is general agreement that the results following vascular surgery are less satisfactory if the runoff is poor. The same has been reported with TLD, although some have suggested that the adequacy of the runoff is of little or no importance. 5"8"11'12 This divergence of opinion is likely due to the fact that the runoff has not been evaluated very critically. Other variables. Although we previously reported that the success rate was higher in patients with an ankle/brachial systolic blood pressure ratio higher than 0.35, 4 our present results and those of others have not observed a difference between the pre-tld pressure measurements in the successful and unsuccessful cases. 13 In general, it is to be expected that the results will be better when the indication for the procedure is claudicarion and lower when the patient has more severe disease and ischemic rest pain, ulceration, or gangrene are present. In the iliac segment Spence et al. 8 reported that the results were better if the indication was claudication compared with salvage, but in the femoral-popliteal segment the indication did not seem to be a factor. Freiman et al.12 noted an overall early success rate of 91.8% for claudication compared with 83% for sal- vage. In our previous analysis we found the presence of diabetes did not adversely affect the results. 1"4 In the iliac segment Spence et al. s reported that the results were the same in diabetics and nondiabetics, but in the femoral-popliteal area the 1-year success rate was 85.4% for nondiaberics and 53.5% for diabetics. Schmidtke et al.14 reported that age had little effect on the results, although we previously reported that patients younger than 55 years had a statistically better long-term result than the older patients. 1,4 The studies reported above have not clearly identified the factors associated with success of a TLD. Furthermore, they have not considered the important interrelationships between variables. When the effect of an individual variable on the outcome is assessed independently of the other variables, their interrelated effects are disregarded. In fact, it is to be expected that all of the significant variables will have interrelated effects, and consequently the effect of each individual variable on the result of the TLD will be confounded by the presence of other significant variables. This distortion in the estimate of the chances of a successful TLD can be handled by using logistic discriminant function analysis to identify the variables associated with success and logistic regression analysis to estimate the probabilities of success for a specific combination of significant variables. '~ In this study of the 10 variables analyzed the logistic discriminant function analysis identified only three as being associated with success at 3 months: the site of the TLD, the severity of the lesion, and the runoff. With the use of logistic regression analysis, a table of the estimated probabilities of success of a TLD at 3 months was constructed for the different combinations of site, severity of the lesion, and runoff. These analyses show that these three factors are strongly interrelated. The probability of early success of a TLD is high if the vessel is stenosed and the runoff is good. If the other factors are equal, common lilac, external iliac, and femoral-popliteal dilatations all have a high probability of early success, but the results are less sarisfactory when multiple iliac dilatations of both the common and the external iliac arteries are performed. The mathematical model appears to be quite accurate since the calculated number of successful dilatations closely agrees with the actual number of successes. Nonetheless the estimated probabilities of success in Table I were calculated based on the population of patients studied at the Toronto General Hospital. Therefore they apply only to this or a

6 Volume 1 Number 5 September 1984 Percutaneous transluminal dilatation 709 similar population. One should be cautious in applying this data to unknown or unrelated populations. The table of estimated probabilities have been developed to predict early success (3 months). In the future, with larger numbers of patients available for follow-up at 1 and 2 years, similar analyses will be performed to determine the variables that predict the long-term results. CONCLUSIONS By using discriminant function analysis we have dctcrmined which variables were associated with succcss of a TLD and have developed a table of predicted success rates for the different combinations of site, severity of the lesion, and runoff. No factor can be selected as being more important than the other two in predicting the result of the TLD. Rather, all three variables combined consistently have a significant effect on the result. We wish to acknowledge the financial support of Cook Inc., the assistance of Mrs. Maureen Rae who coordinated the follow-up study, and Mrs. Susan Ungaro and Mrs. Marilyn Bleach who performed the vascular laboratory studies. REFERENCES 1. Johnston KW, Colapinto RF. Peripheral arterial transluminal dilatation: Early results. Can J Surg I982; 25: Johnston KW. A surgeon's view of peripheral arterial transluminal dilatation. In: Bergan JJ, ed. Clinical surgery international, vol 7. New York: Churchill Livingstone, Gruntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty with the Gruntzig balloon catheter. AJR I979; i32: Johnston KW, Colapinto RF, Baird RJ. Transluminal dilatation--an alternative? Arch Surg 1982; 117: Neiman HL, Bergan JJ, Yao JS, Bran& TD, Greenberg M, O'Mara CS. Hemodynamic assessment of transluminal angioplasty for lower extremity ischemia. Radiology 1982; 143: Neiman IlL, Brandt TD, Greenberg M. Percutaneous transluminal angioplasty: an angiographer's viewpoint. Arch Surg 1981; 116: Roberts B, Ring EJ. Current stares of percutaneous transluminal angioplasty. Surg Clin North Am 1982; 62: Spence RK, Freiman DB, Gatenby R, Hobbs CL, Barker CF, et al. Long-term results of transluminal angioplasty of the iliac and femoral arteries. Arch Surg 1981; 116: Waltrnan AC, Greenfield AJ, Novelline RA, Abbott WM, et al. Transktminal angioplasty of the iliac and femoropopliteal arteries. Current status. Arch Surg 1982; 117: Gnmtzig A, Zeitler E. Coopcrative study of results of PTR in 12 different clinics. In: Zeitler E, Gruntzig A, Schoop W, eds. Percutaneous vascular recanalization. Berlin: Springer- Verlag, 1978: Lu CT, Zarins CK, Yang CF, Sottiurai V. Long-term arterial occlusion: Percutaneous transluminal angioplasty. AJR 1982; 138: Freiman DB, Spence R, Gatcnby R, Gertner M, Robcrts B, Berkowitz HD, et al. Transluminal angioplasty of the iliac and femoral arteries: Follow-up results without anticoagulation. Radiology 1981; 141: Kaufman SL, Barth KH, Kadir S, Williams GM, Smith GW, et al. Hemodynamic measurements in the evaluation and follow-up of transluminal angioplasty of the iliac and femoral arteries. Radiology 1982; 142: Schmidtke I, Zeitler E, Schoop W. Late results ofpercutaneous catheter treatment (Dotter's technique) in occlusion of the femoro-popliteal arteries, Stage. In: Zeitler E, Gruntzig A, Schoop W, eds. Percutaneous vascular recanalization. Berlin: Springer-Verlag, 1978: Anderson S, et al. Logit analysis. In: Anderson S, Auquier A, Hauck WW, Oakes D, Vandaele W, Weisberg HI, eds. Statistical methods for comparative studies. Techniques for bias reduction. New York: John Wiley & Sons, Inc, 1980:7-17,

Factors that determine the long-term results of percutaneous transluminal dilatation for peripheral arterial occlusive disease

Factors that determine the long-term results of percutaneous transluminal dilatation for peripheral arterial occlusive disease Factors that determine the long-term results of percutaneous transluminal dilatation for peripheral arterial occlusive disease Jean F. Morin, M.D., F.R.C.S.(C), K. Wayne Johnston, M.D., F.R.C.S.(C), Larry

More information

Reporting standards arterial endovascular. for lower extremity procedures

Reporting standards arterial endovascular. for lower extremity procedures Reporting standards arterial endovascular for lower extremity procedures Samuel S. Ahn, MD, Robert B. Rutherford, MD, Gary J. Becker, MD, Anthony J. Comerota, MD, K. Wayne Johnston, MD, Gordon K. McClean,

More information

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Practical Point in Holistic Diabetic Foot Care 3 March 2016 Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai

More information

Therapeutic Angiography

Therapeutic Angiography Therapeutic Angiography Edited by C. A. Athanasoulis H. L. Abrams E. Zeitler Contributors K. Amplatz. K.H. Barth J.J. Bookstein. D.e. Brewster V.P. Chuang A.M. Cohen R.F. Colapinto. A.B. Co simi. N.P.

More information

CardioVascular Radiology

CardioVascular Radiology Cardiovasc. Radiol. 2: 3-7, 1979 CardioVascular Radiology Percutaneous Transluminal Angioplasty (PTA) with the Griintzig Balloon Catheter: Technical Problems Encountered in the First Forty Patients B.T.

More information

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery

More information

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/30/2012 Radiology Quiz of the Week # 79 Page 1 CLINICAL PRESENTATION AND RADIOLOGY

More information

Practical Point in Diabetic Foot Care 3-4 July 2017

Practical Point in Diabetic Foot Care 3-4 July 2017 Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University

More information

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D. Lower Extremity Peripheral Arterial Disease: Less is Sometimes More Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity

More information

Thermal laser-assisted balloon angioplasty of the superficial femoral artery: A multicenter review of 602 cases

Thermal laser-assisted balloon angioplasty of the superficial femoral artery: A multicenter review of 602 cases Thermal laser-assisted balloon angioplasty of the superficial femoral artery: A multicenter review of 602 cases David Rosenthal, MD, Felix A. Pesa, MD, Warren L. Gottsegen, MD, John R. Crew, MD, Charles

More information

Arthroplasty after previous surgery: previous vascular problems

Arthroplasty after previous surgery: previous vascular problems Arthroplasty after previous surgery: previous vascular problems Jacques Menetrey & Victoria B. Duthon Centre de médecine de l appareil locomoteur et du sport Swiss Olympic medical Center Unité d Orthopédie

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania

Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania ENDOVASCULAR TREATMENT FOR VASCULAR GRAFT RESTENOSIS Bogdan Totolici 1, Francisca Blanca Călinescu 1*, Ionel Droc 2, Carmen Neamţu 1 1 Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy

More information

Non-invasive examination

Non-invasive examination Non-invasive examination Segmental pressure and Ankle-Brachial Index (ABI) The segmental blood pressure (SBP) examination is a simple, noninvasive method for diagnosing and localizing arterial disease.

More information

Percutaneous Angioplasty for Infrainguinal Graft-related Stenoses

Percutaneous Angioplasty for Infrainguinal Graft-related Stenoses Eur J Vasc Endovasc Surg 14, 380-385 (1997) Percutaneous Angioplasty for Infrainguinal Graft-related Stenoses A. D. Houghton ~1, C. Todd 1, B. Pardy 2, P. R. Taylor ~ and J. F. Reidy ~ Departments of Surgery,

More information

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you

More information

Does Deep Femoral Artery Revascularization as an Isolated Procedure Play a Role in Chronic Critical Limb Ischemia?

Does Deep Femoral Artery Revascularization as an Isolated Procedure Play a Role in Chronic Critical Limb Ischemia? J ENDOVASC THER 119 CLINICAL INVESTIGATION Does Deep Femoral Artery Revascularization as an Isolated Procedure Play a Role in Chronic Critical Limb Ischemia? Nicolas Diehm, MD; Hannu Savolainen, MD*; Felix

More information

Peripheral Arterial Disease: A Practical Approach

Peripheral Arterial Disease: A Practical Approach Peripheral Arterial Disease: A Practical Approach Sanjoy Kundu BSc, MD, FRCPC, DABR, FASA, FCIRSE, FSIR The Scarborough Hospital Toronto Endovascular Centre The Vein Institute of Toronto Scarborough Vascular

More information

Introduction History Preceded by Arterial Doppler and ABI Indications

Introduction History Preceded by Arterial Doppler and ABI Indications Elise Brady, RVT, RDMS Introduction History Preceded by Arterial Doppler and ABI Indications 1) Abnormal ABI (within 2weeks of duplex) 2) Abnormal Doppler waveforms 3) Claudication 4) History of PVD 5)

More information

Radiologic Evaluation of Peripheral Arterial Disease

Radiologic Evaluation of Peripheral Arterial Disease January 2003 Radiologic Evaluation of Peripheral Arterial Disease Grace Tye, Harvard Medical School Year III Patient D.M. CC: 44 y/o male with pain in his buttocks Occurs after walking 2 blocks. Pain is

More information

Current Status of Endovascular Therapies for Critical Limb Ischemia

Current Status of Endovascular Therapies for Critical Limb Ischemia Current Status of Endovascular Therapies for Critical Limb Ischemia Bulent Arslan, MD Associate Professor of Radiology Director, Vascular & Interventional Radiology Rush University Medical Center bulent_arslan@rush.edu

More information

N. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia

N. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia Duplex scan surveillance prosthetic bypass grafts of infrainguinal N. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia Purpose: Surveillance

More information

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center

More information

Pedal Bypass With Deep Venous Arterialization:

Pedal Bypass With Deep Venous Arterialization: Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj

More information

MR Angiography in the evaluation of Lower Extremity Arterial Disease

MR Angiography in the evaluation of Lower Extremity Arterial Disease March 2001 MR Angiography in the evaluation of Lower Extremity Arterial Disease Ted Mau, Harvard Medical School Year III Objectives We will cover: Indications for Magnetic Resonance Angiography (MRA) Basic

More information

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What

More information

Noninvasive localization of arterial occlusive disease: A comparison of segmental Doppler pressures and arterial duplex mapping

Noninvasive localization of arterial occlusive disease: A comparison of segmental Doppler pressures and arterial duplex mapping Noninvasive localization of arterial occlusive disease: A comparison of segmental Doppler pressures and arterial duplex mapping Gregory L. Moneta, MD, Richard A. Yeager, MD, Raymond W. Lee, MD, and John

More information

Subintimal Angioplasty of Isolated Infragenicular Vessels in Lower Limb Ischemia: Long-term Results

Subintimal Angioplasty of Isolated Infragenicular Vessels in Lower Limb Ischemia: Long-term Results 411 CLINICAL INVESTIGATION Subintimal Angioplasty of Isolated Infragenicular Vessels in Lower Limb Ischemia: Long-term Results Hemant Ingle, MS, FRCS; Ahktar Nasim, MD, FRCS; Amman Bolia, FRCR; Guy Fishwick,

More information

V.A. is a 62-year-old male who presents in referral

V.A. is a 62-year-old male who presents in referral , LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.

More information

Comparing patency rates between external iliac and common iliac artery stents

Comparing patency rates between external iliac and common iliac artery stents Comparing patency rates between external iliac and common iliac artery stents Eugene S. Lee, MD, Carol Coleman Steenson, MD, FACR, FSCVIR, Kristina E. Trimble, Michael P. Caldwell, BS, Michael A. Kuskowski,

More information

Study population The study population comprised patients suffering from superficial femoral artery stenosis that required revascularisation.

Study population The study population comprised patients suffering from superficial femoral artery stenosis that required revascularisation. Maintenance of patency following remote superficial femoral artery endarterectomy Galland R B, Whiteley M S, Gibson M, Simmons M J, Torrie E P, Magee T R Record Status This is a critical abstract of an

More information

Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty

Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Poster No.: C-2067 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Interventional

More information

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Current Vascular and Endovascular Management in Diabetic Vasculopathy Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery

More information

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND

More information

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,

More information

SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS

SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS LIBBY WATCH, MD MIAMI VASCULAR SPECIALISTS MIAMI CARDIAC & VASCULAR INSTITUTE FINANCIAL DISCLOSURES None 2

More information

Outcome and Good Indication of Laser Angioplasty

Outcome and Good Indication of Laser Angioplasty The 8th Congress of International YAG Laser Symposium Outcome and Good Indication of Laser Angioplasty Shoichi Takekawa, Hiraku Yodono, Tamaki Kimura, NaokoNishi, Hiroyuki Miura, Hiroshi Noda, Hideya Matsutani,

More information

Clinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases

Clinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases Original paper Clinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases Sakir Arslan, Isa Oner Yuksel, Erkan Koklu, Goksel

More information

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene

More information

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N. Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal

More information

Chronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis

Chronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis Chronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis JAMIE D. SANTILLI, M.D., and STEVEN M. SANTILLI, M.D., PH.D. University of Minnesota School of Medicine Minneapolis, Minnesota Chronic

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Remote Endarterectomy Update

Remote Endarterectomy Update Remote Endarterectomy Update An endovascular alternative to bypass? BY JOHN D. MARTIN, MD Treating the superficial femoral artery (SFA) is still one of the most highly debated topics among vascular specialists.

More information

with laser-assisted balloon and a rotary angioplasty Lessons learned

with laser-assisted balloon and a rotary angioplasty Lessons learned Experience angioplasty instrument: with laser-assisted balloon and a rotary angioplasty Lessons learned David L. Cull, MD, Richard L. Feinberg, MD, Jock R. Wheeler, MD, Stanley O. Snyder, Jr., MD, Roger

More information

Prof. Nabil CHAKFE et coll.

Prof. Nabil CHAKFE et coll. Prof. Nabil CHAKFE et coll. For the Department of Vascular Surgery and Kidney Transplantation University Hospital of Strasbourg, FRANCE Popliteal artery entrapment: misdiagnosed Epidemiology Prevalence:

More information

Resident Teaching Conference 3/12/2010

Resident Teaching Conference 3/12/2010 Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute

More information

Hypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis

Hypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis

More information

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate

More information

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons What's New on the Vascular Horizons? NCVH New Cardiovascular Horizons KNOW YOUR OPTIONS Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans,

More information

Peripheral Arterial Disease: the growing role of endovascular management

Peripheral Arterial Disease: the growing role of endovascular management Peripheral Arterial Disease: the growing role of endovascular management Poster No.: C-1931 Congress: ECR 2012 Type: Educational Exhibit Authors: E. M. C. Guedes Pinto, E. Rosado, D. Penha, P. Cabral,

More information

Surgical transluminal femoropopliteal angioplasty: Multivariate analysis outcome

Surgical transluminal femoropopliteal angioplasty: Multivariate analysis outcome Surgical transluminal femoropopliteal angioplasty: Multivariate analysis outcome Jean-Pierre Becquemin, MD, A. Cavillon, MD, and F. Haiduc, MD, Creteil, France Purpose: The purpose of this study was to

More information

Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions

Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions Vinayak Subramanian, BS 1 ; George L. Adams, MD, MHS 2 From 1 Department of Biomedical Engineering, North Carolina

More information

National Vascular Registry

National Vascular Registry National Vascular Registry Angioplasty Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker

More information

Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts

Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts Disclosure Speaker name: Matthew T. Menard... x I do not have

More information

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical

More information

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular

More information

Endovascular Repair of Combined Occluded Femoral and Popliteal Arteries

Endovascular Repair of Combined Occluded Femoral and Popliteal Arteries MEET 2013 Endovascular Repair of Combined Occluded Femoral and Popliteal Arteries ALI AMIN MD, FACS,FACC, RVT CHIEF OF ENDOVASCULAR INTERVENTIONS READING HOSPITAL AND MEDICAL CENTER READING, PA USA Chronic

More information

Clinical and social consequences of Buerger disease

Clinical and social consequences of Buerger disease Clinical and social consequences of Buerger disease Takashi Ohta, MD, Hiroyuki Ishioashi, MD, Minoru Hosaka, MD, and Ikuo Sugimoto, MD, Aichi, Japan Purpose: This study was undertaken to assess the clinical

More information

PUT YOUR BEST FOOT FORWARD

PUT YOUR BEST FOOT FORWARD PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.

More information

Interventional Treatment First for CLI

Interventional Treatment First for CLI Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant

More information

Should We Be More Aggressive in the Treatment of Acute DVT?

Should We Be More Aggressive in the Treatment of Acute DVT? DISCLOSURES Consultant Penumbra, Inc. UCSF Vascular Surgery Symposium April 6, 2017 K. Pallav Kolli, MD Assistant Professor of Clinical Radiology University of California, San Francisco 17 yo male, DVT

More information

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION ARMANDO MANSILHA MD, PhD, FEBVS UNIVERSITY HOSPITAL - PORTO Disclosure of Interest Speaker name: ARMANDO MANSILHA I have the following potential conflicts

More information

fibrinolysis in peripheral

fibrinolysis in peripheral Low-dose direct vascular disease fibrinolysis in peripheral Barry T. Katzen, M.D., Keith C. Edwards, M.D., Arthur S. Albert, M.D., and Arina van Breda, M.D., Alexandria, Va. One hundred thirty patients

More information

BEST-CLI Trial Study Concept and Current Status

BEST-CLI Trial Study Concept and Current Status BEST-CLI Trial Study Concept and Current Status Kenneth Rosenfield, MD, MHCDS National Co-PI BEST-CLI Trial Section Head, Vascular Medicine and Intervention Institute for Heart, Vascular, and Stroke Care

More information

Influence of vein size (diameter) on infrapopliteal reversed vein graft patency

Influence of vein size (diameter) on infrapopliteal reversed vein graft patency Influence of vein size (diameter) on infrapopliteal reversed vein graft patency Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushil K. Gupta, MD, Enrico Ascer, MD, and Steven P. Rivers, MD, New York, N.Y.

More information

Laser Thermal Angioplasty for the Treatment of Obstruction of the Distal Superficial Femoral or Popliteal Arteries

Laser Thermal Angioplasty for the Treatment of Obstruction of the Distal Superficial Femoral or Popliteal Arteries 1 i 69 Tirnothy C. McCowan1 Ernest J. Ferns1 Robert W. Barnes2 Max L. Baker1 Received November 1 0, 1987: accepted after revision January 21, 1988. T. C. McCowan is supported in part by The RadiOlOgical

More information

FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in

FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in 11 Evaluation and Management of Peripheral Arterial Disease Joseph L. Mills, Sr., MD FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in the United States, foot problems ulceration, infection, and

More information

RadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.

RadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved. Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of November 19, 2018 Abdominal Aortogram, Bilateral Runoff

More information

Value of the duplex waveform at the common femoral artery for diagnosing obstructive aortoiliac disease

Value of the duplex waveform at the common femoral artery for diagnosing obstructive aortoiliac disease Value of the duplex waveform at the common femoral artery for diagnosing obstructive aortoiliac disease Sandra Spronk, MSc, a Pieter T. den Hoed, MD, PhD, b Leenoud C. W. de Jonge, MD, c Lukas C. van Dijk,

More information

Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries

Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries Laura A. Karch, MD, Mark A. Mattos, MD, John P. Henretta, MD, Robert B. McLafferty, MD, Don

More information

Iliac artery stenting in patients with poor distal runoff: Influence of concomitant infrainguinal arterial reconstruction

Iliac artery stenting in patients with poor distal runoff: Influence of concomitant infrainguinal arterial reconstruction Iliac artery stenting in patients with poor distal runoff: Influence of concomitant infrainguinal arterial reconstruction Carlos H. Timaran, MD, a Takao Ohki, MD, a Nicholas J. Gargiulo, III, MD, a Frank

More information

Predictors for adverse outcome after iliac angioplasty and stenting for limb-threatening ischemia

Predictors for adverse outcome after iliac angioplasty and stenting for limb-threatening ischemia Predictors for adverse outcome after iliac angioplasty and stenting for limb-threatening ischemia Carlos H. Timaran, MD, Scott L. Stevens, MD, Michael B. Freeman, MD, and Mitchell H. Goldman, MD, Knoxville,

More information

2017 Cardiology Survival Guide

2017 Cardiology Survival Guide 2017 Cardiology Survival Guide Chapter 2: Angioplasty/Atherectomy/Stent The term angioplasty literally means "blood vessel repair." During an angioplasty procedure, the physician inserts a catheter, with

More information

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012 Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? Easy 89 yo Non-ambulatory Multiple failed interventions Forefoot and heel gangrene Andres Schanzer, MD

More information

Durability of vein graft revision: The outcome of secondary procedures

Durability of vein graft revision: The outcome of secondary procedures Durability of vein graft revision: The outcome of secondary procedures Dennis F. Bandyk, MD, Thomas M. Bergamini, MD, Jonathan B. Towne, MD, David D. Schmitt, MD, and Gary R. Seabrook, MD, Milwaukee, Wis.

More information

Angioplasty of the tibioperoneal vessels has had limited

Angioplasty of the tibioperoneal vessels has had limited Tibioperoneal (Outflow Lesion) Angioplasty Can Be Used as Primary Treatment in 235 Patients With Critical Limb Ischemia Five-Year Follow-Up Gerald Dorros, MD; Michael R. Jaff, DO; Ari M. Dorros, MD; Lynne

More information

Superficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA

Superficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA : The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA Peripheral arterial disease (PAD) of the superficial femoral artery (SFA) is the most common cause of intermittent claudication

More information

Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis?

Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis? Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis? Gerald S. Treiman, MD, Richard L. Treiman, MD, Laura Ichikawa,

More information

National Vascular Registry

National Vascular Registry National Vascular Registry Bypass Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or postcode.

More information

Distal By-Pass procedures can reduce limb loss

Distal By-Pass procedures can reduce limb loss Conventional treatment of the diabetic foot Distal By-Pass procedures can reduce limb loss Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department of Surgery,

More information

Mandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium

Mandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc

More information

Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease

Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease Eur J Vasc Endovasc Surg (2010) 39, 714e718 Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease G. Styczynski a, *, C. Szmigielski a, J. Leszczynski b, A. Kuch-Wocial a, M. Szulc a a

More information

There are multiple endovascular options for treatment

There are multiple endovascular options for treatment Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA

More information

Perfusion Assessment in Chronic Wounds

Perfusion Assessment in Chronic Wounds Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,

More information

Indications: following: embolization. artery that has diseases 5. The evaluation. of suspected. such entities. a cold hand. biopsy

Indications: following: embolization. artery that has diseases 5. The evaluation. of suspected. such entities. a cold hand. biopsy Peripheral Arterial Ultrasound Protocol Using Color and Spectral Doppler Reviewed by: Mark Yuhasz, MD Last Review Date: January 2015 Contact: (866) 761 4200, Option 1 Indications: The indications for peripheral

More information

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009 Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting

More information

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE Michael S. Conte MD Professor and Chief, Vascular and Endovascular Surgery Co-Director, Center for Limb Preservation Co-Director, Heart and Vascular

More information

peripheral arterial disease; PAD endovascular therapy; EVT

peripheral arterial disease; PAD endovascular therapy; EVT 15 603 610 2006 1 1 1 1 1 2 3 1 2 peripheral arterial disease; PAD endovascular therapy; EVT chronic total occlusion; CTO CTO TASC-C DEVT 1997 7 2006 4 PAD 171 218 EVTCTO60 61 51 9 70 8.6cm 8049 1 9 2

More information

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,

More information

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Disclosure I have nothing to disclose Randomized Controlled Studies In SFA Technology: What s The Best Tool For

More information

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare

More information

Lower Extremity Arterial Duplex Evaluation

Lower Extremity Arterial Duplex Evaluation VASCULAR TECHNOLOGY PROFESSIONAL PERFORMANCE GUIDELINES Lower Extremity Arterial Duplex Evaluation This Guideline was prepared by the Professional Guidelines Subcommittee of the Society for Vascular Ultrasound

More information

Angiographic follow-up after laser-assisted balloon angioplasty

Angiographic follow-up after laser-assisted balloon angioplasty Angiographic follow-up after laser-assisted balloon angioplasty Bhagwan Satiani, MD, B. Mohan Das, MD, Patrick S. Vaccaro, MD, and Diane Gawron, RN, Columbus, Ohio Purpose: The purpose of this study was

More information